YU49138B - Proteinski derivat humane lipaze stimulisane žučnom soli - Google Patents

Proteinski derivat humane lipaze stimulisane žučnom soli

Info

Publication number
YU49138B
YU49138B YU95191A YU95191A YU49138B YU 49138 B YU49138 B YU 49138B YU 95191 A YU95191 A YU 95191A YU 95191 A YU95191 A YU 95191A YU 49138 B YU49138 B YU 49138B
Authority
YU
Yugoslavia
Prior art keywords
bile salt
protein derivative
human lipase
lipase stimulated
stimulated
Prior art date
Application number
YU95191A
Other languages
English (en)
Other versions
YU95191A (sh
Inventor
Gunnar Bjursell
Lars Bläckberg
Peter Carlsson
Sven Enerbäck
Olle Hernell
Jeanette Nilsson
Thomas Olivecrona
Original Assignee
Aktiebolaget Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktiebolaget Astra filed Critical Aktiebolaget Astra
Priority to HRP-951/91A priority Critical patent/HRP920771B1/xx
Publication of YU95191A publication Critical patent/YU95191A/sh
Publication of YU49138B publication Critical patent/YU49138B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/596—Mixtures of surface active compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Protein kao što je naznačen na slici VII od položaja 1 do položaja 722. Prijava sadrži još 4 nezavisna i 13 zavisnih zahteva.
YU95191A 1990-06-01 1991-05-29 Proteinski derivat humane lipaze stimulisane žučnom soli YU49138B (sh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HRP-951/91A HRP920771B1 (en) 1990-06-01 1992-10-01 New chemical products

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9001985A SE9001985D0 (sv) 1990-06-01 1990-06-01 New chemical products

Publications (2)

Publication Number Publication Date
YU95191A YU95191A (sh) 1994-06-10
YU49138B true YU49138B (sh) 2004-03-12

Family

ID=20379662

Family Applications (1)

Application Number Title Priority Date Filing Date
YU95191A YU49138B (sh) 1990-06-01 1991-05-29 Proteinski derivat humane lipaze stimulisane žučnom soli

Country Status (44)

Country Link
EP (1) EP0535048B1 (sh)
JP (1) JPH05507201A (sh)
KR (1) KR100212411B1 (sh)
CN (2) CN1075113C (sh)
AP (1) AP207A (sh)
AT (1) ATE151077T1 (sh)
AU (1) AU651979B2 (sh)
BG (1) BG61165B1 (sh)
CA (1) CA2083396C (sh)
CZ (1) CZ287470B6 (sh)
DE (1) DE69125489T2 (sh)
DK (1) DK0535048T3 (sh)
DZ (1) DZ1503A1 (sh)
EG (1) EG19937A (sh)
ES (1) ES2099159T3 (sh)
FI (1) FI114639B (sh)
GR (1) GR3023618T3 (sh)
HK (1) HK62497A (sh)
HR (1) HRP920771B1 (sh)
HU (1) HU215258B (sh)
IE (1) IE911844A1 (sh)
IL (1) IL98273A (sh)
IS (1) IS1751B (sh)
JO (1) JO1694B1 (sh)
LT (1) LT4020B (sh)
LV (1) LV10292B (sh)
MA (1) MA22166A1 (sh)
MY (1) MY111245A (sh)
NO (1) NO322962B1 (sh)
NZ (1) NZ238223A (sh)
PH (1) PH30761A (sh)
PL (1) PL166534B1 (sh)
PT (1) PT97836B (sh)
RO (1) RO114793B1 (sh)
RU (1) RU2140983C1 (sh)
SE (1) SE9001985D0 (sh)
SG (1) SG48078A1 (sh)
SK (1) SK281089B6 (sh)
TN (1) TNSN91041A1 (sh)
TW (1) TW221712B (sh)
UA (1) UA39165C2 (sh)
WO (1) WO1991018923A1 (sh)
YU (1) YU49138B (sh)
ZA (1) ZA913778B (sh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616483A (en) * 1992-06-11 1997-04-01 Aktiebolaget Astra Genomic DNA sequences encoding human BSSL/CEL
IS4130A (is) * 1993-03-01 1994-09-02 Ab Astra Ný fjölpeptíð
SE9300686D0 (sv) 1993-03-01 1993-03-01 Astra Ab Novel polypeptides
FR2754827B1 (fr) * 1996-10-17 1998-12-24 Biocem Lipases pancreatiques et/ou colipases recombinantes et polypeptides dervies produits par les plantes, leurs procedes d'obtention et leurs utilisations
JP2000026311A (ja) 1998-07-02 2000-01-25 Amano Pharmaceut Co Ltd 胃排出能亢進剤組成物
EP1963524A2 (en) * 2005-12-01 2008-09-03 University of Bergen Diagnosis and treatment of exocrine pancreatic dysfunction and diabetes using human cel gene
WO2011133960A2 (en) 2010-04-23 2011-10-27 Synageva Biopharma Corp Lysosomal storage disease enzyme
NZ700824A (en) 2010-09-09 2016-03-31 Synageva Biopharma Corp Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients
CN103200957A (zh) 2010-10-21 2013-07-10 瑞典孤儿比奥维特鲁姆有限公司 提高人婴儿之生长速度的方法
EP2629789A1 (en) 2010-10-21 2013-08-28 Swedish Orphan Biovitrum AB (Publ) Method to increase the absorption of unsaturated fatty acids by human infants
KR20200018781A (ko) * 2017-06-19 2020-02-20 스위디쉬 오르펀 바이오비트럼 에이비 (피유비엘) 반감기 연장 폴리펩티드를 갖는 융합 단백질
KR20220106738A (ko) 2019-08-30 2022-07-29 코덱시스, 인코포레이티드 조작된 리파제 변이체

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2142337A (en) * 1983-07-01 1985-01-16 Celltech Ltd Preparation of lingual lipase protein

Also Published As

Publication number Publication date
IS3710A7 (is) 1991-12-02
DK0535048T3 (da) 1997-09-29
LTIP1736A (en) 1995-08-25
YU95191A (sh) 1994-06-10
HRP920771B1 (en) 1999-10-31
EP0535048B1 (en) 1997-04-02
KR100212411B1 (en) 1999-08-02
PT97836B (pt) 1998-11-30
LV10292B (en) 1995-08-20
PT97836A (pt) 1992-02-28
IL98273A0 (en) 1992-06-21
IL98273A (en) 2005-11-20
EG19937A (en) 2000-12-31
SE9001985D0 (sv) 1990-06-01
ATE151077T1 (de) 1997-04-15
DZ1503A1 (fr) 2004-09-13
PL166534B1 (pl) 1995-05-31
FI114639B (fi) 2004-11-30
WO1991018923A1 (en) 1991-12-12
CN1075113C (zh) 2001-11-21
LV10292A (lv) 1994-10-20
ES2099159T3 (es) 1997-05-16
RU2140983C1 (ru) 1999-11-10
AP9100270A0 (en) 1991-07-31
PH30761A (en) 1997-10-17
CZ287470B6 (cs) 2000-12-13
ZA913778B (en) 1992-02-26
GR3023618T3 (en) 1997-08-29
HUT63184A (en) 1993-07-28
SK281089B6 (sk) 2000-11-07
DE69125489D1 (de) 1997-05-07
BG61165B1 (bg) 1997-01-31
HRP920771A2 (en) 1997-04-30
FI925453A (fi) 1992-11-30
TNSN91041A1 (fr) 1992-10-25
JO1694B1 (en) 1992-08-09
SG48078A1 (en) 1998-04-17
AU7964591A (en) 1991-12-31
AP207A (en) 1992-08-18
NO924528L (no) 1992-11-24
CN1064313A (zh) 1992-09-09
NO322962B1 (no) 2006-12-18
TW221712B (sh) 1994-03-11
MY111245A (en) 1999-10-30
HU9203774D0 (en) 1993-03-29
NZ238223A (en) 1993-05-26
LT4020B (en) 1996-08-26
SK164491A3 (en) 1995-07-11
CA2083396A1 (en) 1991-12-02
CA2083396C (en) 2006-09-19
AU651979B2 (en) 1994-08-11
FI925453A0 (fi) 1992-11-30
JPH05507201A (ja) 1993-10-21
DE69125489T2 (de) 1997-08-14
RO114793B1 (ro) 1999-07-30
IS1751B (is) 2000-07-21
CZ164491A3 (cs) 1999-07-14
HU215258B (hu) 1998-11-30
MA22166A1 (fr) 1991-12-31
UA39165C2 (uk) 2001-06-15
EP0535048A1 (en) 1993-04-07
BG97123A (bg) 1993-12-24
IE911844A1 (en) 1991-12-04
NO924528D0 (no) 1992-11-24
HK62497A (en) 1997-05-16
CN1326782A (zh) 2001-12-19

Similar Documents

Publication Publication Date Title
ITMI920162A1 (it) Metodo per mantenere l'attivita' di enzimi proteolitici modificati con polietilenglicole
ATE254443T1 (de) Inhibitierung des haarwuchses
AT383428B (de) Brillengestell zur verbesserung des natuerlichen hoerens
DK0714300T3 (da) Fremgangsmåder til regulering af den seksuelle reaktion hos mennesker
LV11895A (lv) 4-benzoilpirazola atvasinajumi un to pielietojums par herbicidiem
IT8148188A0 (it) Procedimento e composizione per eliminare l'odore di ammoniaca da rifiuti organici
MC1423A1 (fr) Production microbienne d'interferon de fibroplaste humain
DE69637669D1 (de) Myogene differenzierung menschlicher mesenchymaler stammzellen
MX9405383A (es) Imidazo(4,5-c) piridin-4-aminas.
IT9067125A0 (it) Protesi valvolare cardiaca
DE69117333D1 (de) Anzeigesteuergerät zur Verminderung des Leistungsverbrauchs
DE3484997D1 (de) Zellstimulierendes mittel.
ZA9169B (en) Methods and compositions to disinfect lenses
YU49138B (sh) Proteinski derivat humane lipaze stimulisane žučnom soli
DK501389A (da) Hoereapparat med organer til at undertrykke uoensket tilbagekobling
ES2016920A4 (es) Procedimiento de realizacion de barras anti-torsion por encolado in situ de cojinetes elasticos y barras anti-torsion realizadas segun el procedimiento.
IT1124579B (it) Metodo e complesso per l'addamento di protesi acustiche
FR2495635B1 (fr) Production d'urokinase humaine
ATE215810T1 (de) Abschuppungs-zusammensetzung
ATE210989T1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
AU9034291A (en) Derivates of the human parathormone fragment (1-37) in the amide or ethylamide form as active substance
IT7824578A0 (it) Composizione farmaceutica per la terapia di stati di frigidita' ed impotenza.
BR9100445A (pt) Composicao estavel de dispersao pesticida aquosa
LV12032A (lv) Pesticidu kompozcijas un to iegusanas panemiens
IT8049317A0 (it) Perfezionamento nelle protesi di valvole cardiache